DE60104240D1 - Makrolid-Antibiotika - Google Patents

Makrolid-Antibiotika

Info

Publication number
DE60104240D1
DE60104240D1 DE60104240T DE60104240T DE60104240D1 DE 60104240 D1 DE60104240 D1 DE 60104240D1 DE 60104240 T DE60104240 T DE 60104240T DE 60104240 T DE60104240 T DE 60104240T DE 60104240 D1 DE60104240 D1 DE 60104240D1
Authority
DE
Germany
Prior art keywords
compounds
formula
methods
infections
macrolide antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60104240T
Other languages
English (en)
Other versions
DE60104240T2 (de
Inventor
Takushi Kaneko
William Thomas Mcmillen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of DE60104240D1 publication Critical patent/DE60104240D1/de
Publication of DE60104240T2 publication Critical patent/DE60104240T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60104240T 2000-06-30 2001-06-21 Makrolid-Antibiotika Expired - Fee Related DE60104240T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21523700P 2000-06-30 2000-06-30
US215237P 2000-06-30

Publications (2)

Publication Number Publication Date
DE60104240D1 true DE60104240D1 (de) 2004-08-19
DE60104240T2 DE60104240T2 (de) 2005-08-04

Family

ID=22802202

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60104240T Expired - Fee Related DE60104240T2 (de) 2000-06-30 2001-06-21 Makrolid-Antibiotika

Country Status (12)

Country Link
US (1) US6809080B2 (de)
EP (1) EP1167376B1 (de)
JP (1) JP3587380B2 (de)
AT (1) ATE271062T1 (de)
BR (1) BR0102623A (de)
CA (1) CA2351829C (de)
DE (1) DE60104240T2 (de)
DK (1) DK1167376T3 (de)
ES (1) ES2222966T3 (de)
MX (1) MXPA01006751A (de)
PT (1) PT1167376E (de)
TR (1) TR200401847T4 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4043191B2 (ja) * 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
ID30233A (id) 1999-01-27 2001-11-15 Pfizer Prod Inc Antibiotika ketolida
PL352720A1 (en) 1999-05-24 2003-09-08 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
WO2003070254A1 (en) 2002-02-15 2003-08-28 Sympore Gmbh Antibiotic conjugates
US20040005641A1 (en) 2002-02-15 2004-01-08 Michael Burnet Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
US7579324B2 (en) 2002-02-15 2009-08-25 C-A-I-R Biosciences Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
PL1836211T3 (pl) * 2004-12-21 2010-07-30 Pfizer Prod Inc Makrolidy

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
CO4990960A1 (es) 1997-10-29 2000-12-26 Abbott Lab Derivados de cetolidos 2-halo-6-o sustituidos
US6124269A (en) 1997-10-29 2000-09-26 Abbott Laboratories 2-Halo-6-O-substituted ketolide derivatives
FR2777282B1 (fr) 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
FR2784682B1 (fr) 1998-10-15 2002-12-06 Hoechst Marion Roussel Inc Nouveaux derives 2-halogene de 5-0-desosaminylerythronolide a, leur procede de preparation et leur application comme medicaments
FR2785612A1 (fr) 1998-11-10 2000-05-12 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
JP4043191B2 (ja) * 1998-11-03 2008-02-06 ファイザー・プロダクツ・インク 新規なマクロライド抗生物質
FR2786188B1 (fr) 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
ID30233A (id) 1999-01-27 2001-11-15 Pfizer Prod Inc Antibiotika ketolida
FR2789392B1 (fr) 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
AU775637B2 (en) 1999-04-16 2004-08-12 Kosan Biosciences, Inc. Macrolide antiinfective agents
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6355620B1 (en) * 1999-05-14 2002-03-12 Abbott Laboratories C-2 modified erythromycin derivatives
PL352720A1 (en) 1999-05-24 2003-09-08 Pfizer Products Inc. 13-methyl-erythromycin derivatives
US6569836B2 (en) 1999-12-02 2003-05-27 Abbott Laboratories 6-O-alkyl-2-nor-2-substituted ketolide derivatives
ES2306674T3 (es) 1999-12-02 2008-11-16 Abbott Laboratories Derivados cetolidos 6-o-alquil-2-nor-2-sustituidos.
EP1114826A3 (de) 1999-12-29 2001-10-31 Pfizer Products Inc. Antibakterielle und prokinetische Makroliden

Also Published As

Publication number Publication date
PT1167376E (pt) 2004-09-30
CA2351829A1 (en) 2001-12-30
JP2002265488A (ja) 2002-09-18
JP3587380B2 (ja) 2004-11-10
US20020052328A1 (en) 2002-05-02
MXPA01006751A (es) 2002-10-23
US6809080B2 (en) 2004-10-26
EP1167376B1 (de) 2004-07-14
CA2351829C (en) 2006-01-17
ATE271062T1 (de) 2004-07-15
ES2222966T3 (es) 2005-02-16
EP1167376A1 (de) 2002-01-02
DE60104240T2 (de) 2005-08-04
DK1167376T3 (da) 2004-10-25
TR200401847T4 (tr) 2004-09-21
BR0102623A (pt) 2002-02-13

Similar Documents

Publication Publication Date Title
EA200100623A1 (ru) Кетолидные антибиотики
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
ATE260928T1 (de) Ketolidantibiotika
BG105543A (en) Novel macrolide antibiotics
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
ATE271062T1 (de) Makrolid-antibiotika
YU66900A (sh) Derivati higromicina a
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
YU64300A (sh) Derivati 2"-deoksi higromicina
AP2001002154A0 (en) Hygromycin a derivatives (changed by the ISA to read hygromycin a derivatives as antibacterial agents.
EA200201167A1 (ru) Производные гигромицина а для лечения бактериальных и протозойных инфекций
AP2002002492A0 (en) Hygromycin a prodrugs.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee